-
PD 173074: Selective FGFR1/VEGFR2 Inhibition for Research
2026-07-30
PD 173074 is a nanomolar-potency, highly selective inhibitor of FGFR1 and VEGFR2. It enables precise dissection of FGFR signaling pathway inhibition, angiogenesis, and tumor biology. Its robust selectivity and solubility profile make it indispensable in cancer and translational research.
-
FXR-KLF11 Axis Suppresses JAK2/STAT3 to Protect Against CI-A
2026-07-30
This study uncovers how Chenodeoxycholic Acid (CDCA) activates the FXR-KLF11 transcriptional axis to inhibit JAK2/STAT3 signaling, reducing inflammation and apoptosis in contrast-induced acute kidney injury (CI-AKI) models. The findings highlight a mechanistically defined pathway for renal protection and suggest CDCA as a targeted tool for metabolic and kidney injury research.
-
Lactate-GPR81 Signaling: A Novel Pathway for Insulin-Indepen
2026-07-29
This study uncovers how lactate, via the GPR81/FARP1 pathway, drives glucose uptake and metabolic regulation independently of insulin. These findings reveal new molecular targets for hyperglycemia treatment, offering mechanistic insight and translational potential for metabolic and signaling pathway research.
-
SIRT3-SUMO Regulation of Treg Differentiation in Asthma via
2026-07-29
This study uncovers how SIRT3-SUMO modulates Treg cell differentiation and asthma progression by mediating N-glycosylation through the fatty acid oxidation (FAO) pathway. These findings clarify metabolic and epigenetic mechanisms in immune regulation, suggesting new avenues for targeted asthma therapies.
-
Structure-Based Screening Identifies NSP15 Inhibitors for SA
2026-07-28
This study demonstrated a structure-based virtual screening approach to identify potent inhibitors of the SARS-CoV-2 NSP15 endoribonuclease, revealing thymopentin and oleuropein as promising candidates. The findings provide a framework for leveraging natural product libraries in antiviral research targeting viral immune evasion mechanisms.
-
Brefeldin A (SKU B1400): Reliable Solutions for ER Stress St
2026-07-28
This article addresses common laboratory challenges in cell viability, apoptosis, and vesicular trafficking assays by demonstrating how Brefeldin A (SKU B1400) from APExBIO provides robust, reproducible results. Scenario-based Q&A blocks guide users through experimental design, data interpretation, and product selection, ensuring practical insights for researchers leveraging BFA in ER stress and cancer research.
-
Protease and Phosphatase Inhibitor Cocktail: Advanced Contro
2026-07-27
Explore how the Protease and Phosphatase Inhibitor Cocktail (EDTA Free, 100X in ddH2O) protects labile post-translational modifications during protein extraction. This article reveals unique insights into HMGB1 regulation in sepsis, offering a scientific edge for researchers seeking uncompromised protein integrity.
-
β-Pseudouridine: Reliable RNA Modification for Reproducible
2026-07-27
This article explores the lab-validated applications and advantages of β-Pseudouridine (SKU B8649) in enhancing assay reliability, RNA structure stabilization, and translational fidelity. Through scenario-driven Q&A, it provides practical, evidence-based guidance for researchers seeking improved reproducibility and sensitivity in RNA-focused workflows.
-
Translational Impact of Selective Calpain Inhibition: MDL 28
2026-07-26
This thought-leadership article explores the mechanistic underpinnings and translational opportunities of MDL 28170, a potent, selective calpain and cathepsin B inhibitor. Bridging recent mechanistic discoveries in neurodevelopmental injury with practical protocol guidance, we highlight how MDL 28170 advances neuroprotection research, apoptosis assays, and cross-domain disease models. The discussion synthesizes evidence from primary literature and recent scenario-driven articles, offering actionable insights for translational scientists aiming to optimize their workflows with APExBIO’s MDL 28170.
-
SU6656 Src Tyrosine Kinases Inhibitor: Precision Tools for P
2026-07-25
Explore how SU6656, a Src tyrosine kinases inhibitor, enables unprecedented precision in megakaryocyte polyploidization and radiotherapy sensitization. This article uniquely unpacks protocol parameters and the translational significance of small molecule-driven platelet production.
-
Phenylmethanesulfonyl Fluoride (PMSF): Precision in Protein
2026-07-24
Phenylmethanesulfonyl fluoride (PMSF) is the gold-standard for irreversible serine protease inhibition, safeguarding protein integrity during extraction, Western blotting, and advanced immunological research. Discover actionable workflows, troubleshooting insights, and how PMSF from APExBIO adapts to demanding experimental contexts, including cutting-edge macrophage SARS-CoV-2 models.
-
Ciclesonide in Respiratory Research: Workflow, Protocols & T
2026-07-24
Ciclesonide’s rapid prodrug activation and potent glucocorticoid receptor binding set a new standard for modeling airway inflammation. This article details reproducible workflows, advanced applications, and troubleshooting strategies, empowering respiratory disease researchers to leverage APExBIO’s high-purity Ciclesonide for robust, next-generation assays.
-
Protease and Phosphatase Inhibitor Cocktail: Applied Workflo
2026-07-23
Preserving protein integrity and phosphorylation status during extraction is critical for accurate downstream analyses. This article explores how the Protease and Phosphatase Inhibitor Cocktail (EDTA Free, 100X in ddH2O) empowers robust assays, highlights advanced use-cases, and provides actionable troubleshooting strategies for researchers working with sensitive cell and tissue samples.
-
Protease and Phosphatase Inhibitor Cocktail: Precision in Pr
2026-07-23
The EDTA-free Protease and Phosphatase Inhibitor Cocktail empowers researchers to preserve labile phosphorylation states and protein integrity during demanding extraction workflows. Discover how APExBIO’s advanced formulation enhances post-translational modification studies, with practical workflow optimizations and troubleshooting grounded in the latest translational research.
-
ATF4-Driven DNA Repair in Expanding CUX2+ Cortical Neurons
2026-07-22
This study uncovers the essential role of ATF4 in supporting DNA repair during the evolutionary expansion of upper-layer (L2/3) CUX2+ neurons in the mammalian cortex. By dissecting the transcriptional network underlying neural progenitor survival, the research clarifies why these neurons are uniquely vulnerable and highlights implications for neurodevelopmental and neurodegenerative disorders.